Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer | Breast Cancer | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
 NIH Consensus Development Conference statement on the treatment of early-stage breast cancer.  Oncology (Williston Park). 1991;5(2):120-124.PubMedGoogle Scholar
2.
Lee  MC, Rogers  K, Griffith  K,  et al.  Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center.  Breast J. 2009;15(1):34-40.PubMedGoogle ScholarCrossref
3.
McGuire  KP, Santillan  AA, Kaur  P,  et al.  Are mastectomies on the rise? a 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.  Ann Surg Oncol. 2009;16(10):2682-2690.PubMedGoogle ScholarCrossref
4.
Smith  GL, Xu  Y, Shih  YC,  et al.  Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.  J  Am Coll Surg. 2009;209(4):425.e2-433.e2. PubMedGoogle ScholarCrossref
5.
Lazovich  D, Solomon  CC, Thomas  DB, Moe  RE, White  E.  Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.  Cancer. 1999;86(4):628-637.PubMedGoogle ScholarCrossref
6.
Blichert-Toft  M, Rose  C, Andersen  JA,  et al; Danish Breast Cancer Cooperative Group.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis.  J Natl Cancer Inst Monogr. 1992;(11):19-25.PubMedGoogle Scholar
7.
Fisher  B, Anderson  S, Bryant  J,  et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.  N Engl J Med. 2002;347(16):1233-1241.PubMedGoogle ScholarCrossref
8.
Fisher  B, Redmond  C, Poisson  R,  et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.  N Engl J Med. 1989;320(13):822-828.PubMedGoogle ScholarCrossref
9.
Jatoi  I, Proschan  MA.  Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results.  Am J Clin Oncol. 2005;28(3):289-294.PubMedGoogle ScholarCrossref
10.
Lichter  AS, Lippman  ME, Danforth  DN  Jr,  et al.  Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute.  J Clin Oncol. 1992;10(6):976-983.PubMedGoogle Scholar
11.
Sarrazin  D, Lê  MG, Arriagada  R,  et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.  Radiother Oncol. 1989;14(3):177-184.PubMedGoogle ScholarCrossref
12.
van Dongen  JA, Bartelink  H, Fentiman  IS,  et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.  J Natl Cancer Inst Monogr. 1992;(11):15-18.PubMedGoogle Scholar
13.
Veronesi  U, Saccozzi  R, Del Vecchio  M,  et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.  N Engl J Med. 1981;305(1):6-11.PubMedGoogle ScholarCrossref
14.
Surveillance, Epidemiology, and End Results (SEER) Program. SEER program overview. National Cancer Institute website. http://seer.cancer.gov/about/overview.html. Accessed December 8, 2013.
15.
Crowe  JP  Jr, Gordon  NH, Shenk  RR, Zollinger  RM  Jr, Brumberg  DJ, Shuck  JM.  Primary tumor size. Relevance to breast cancer survival.  Arch Surg. 1992;127(8):910-915, discussion 915-916.PubMedGoogle ScholarCrossref
16.
Gobardhan  PD, Elias  SG, Madsen  EV,  et al.  Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study.  Ann Surg Oncol. 2011;18(6):1657-1664.PubMedGoogle ScholarCrossref
17.
Hwang  ES, Lichtensztajn  DY, Gomez  SL, Fowble  B, Clarke  CA.  Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.  Cancer. 2013;119(7):1402-1411.PubMedGoogle ScholarCrossref
18.
Whelan  T, Olivotto  I, Ackerman  I,  et al.  NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer [abstract LBA1003].  J Clin Oncol. 2011;29(suppl).Google Scholar
Original Investigation
March 2014

Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer

Author Affiliations
  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor
  • 2Huntsman Cancer Institute, Biostatistics Core, University of Utah School of Medicine, Salt Lake City
  • 3Department of Surgery, University of Utah School of Medicine, Salt Lake City
  • 4Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City
JAMA Surg. 2014;149(3):267-274. doi:10.1001/jamasurg.2013.3049
Abstract

Importance  To our knowledge, there are no recent studies that directly compare survival after breast conservation therapy (BCT) vs mastectomy.

Objective  To compare the breast cancer–specific survival rates of patients undergoing BCT, mastectomy alone, or mastectomy with radiation using a contemporary cohort of patients.

Design, Setting, and Participants  We performed univariate, multivariate logistic regression, and propensity analyses to compare the hazard of death for female patients with early-stage invasive ductal carcinoma treated with BCT, mastectomy alone, or mastectomy with radiation during the period from 1998 to 2008. The data were extracted from the Surveillance, Epidemiology, and End Results database. Early-stage breast cancer was defined as having a tumor size of 4 cm or smaller with 3 or less positive lymph nodes.

Exposure  Breast conservation therapy, mastectomy alone, or mastectomy with radiation.

Main Outcomes and Measures  Hazard of death due to breast cancer for patients undergoing BCT, mastectomy alone, or mastectomy with radiation.

Results  A total of 132 149 patients were included in this analysis. Breast conservation therapy was used to treat 70% of patients, mastectomy alone was used to treat 27% of patients, and mastectomy with radiation was used to treat 3% of patients. The 5-year breast cancer–specific survival rates of patients who underwent BCT, a mastectomy alone, or a mastectomy with radiation were 97%, 94%, and 90%, respectively (P < .001); the 10-year breast cancer–specific survival rates were 94%, 90%, and 83%, respectively (P < .001). Multivariate analysis showed that women undergoing BCT had a higher survival rate than those undergoing mastectomy alone (hazard ratio, 1.31; P < .001) or mastectomy with radiation (hazard ratio, 1.47; P < .001). When propensity score stratification was used, the effect of treatment method on survival was similar.

Conclusions and Relevance  Patients who underwent BCT have a higher breast cancer–specific survival rate compared with those treated with mastectomy alone or mastectomy with radiation for early-stage invasive ductal carcinoma. Further investigation is warranted to understand what may be contributing to this effect.

×